Filing Details
- Accession Number:
- 0001213900-25-017946
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-27 15:51:55
- Reporting Period:
- 2024-06-14
- Filing Date:
- 2025-02-27
- Accepted Time:
- 2025-02-27 15:51:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831868 | Seastar Medical Holding Corp | ICU | Surgical & Medical Instruments & Apparatus (3841) | 853681132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2026279 | John Neuman | C/O Seastar Medical Holding Corporation 3513 Brighton Blvd., Suite 410 Denver CO 80216 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2024-06-14 | 10,000 | $3.69 | 10,000 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2024-06-17 | 10,000 | $4.35 | 20,000 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2024-08-15 | 10,000 | $5.24 | 30,000 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2024-12-11 | 10,000 | $2.04 | 40,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- 1. The price reported in Column 4 is a weighted average price of $3.6905. These shares were purchased in multiple transactions at prices ranging from $3.67 to $3.71, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- 2. The price reported in Column 4 is a weighted average price of $4.3521. These shares were purchased in multiple transactions at prices ranging from $4.29 to $4.37, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- 3. The price reported in Column 4 is a weighted average price of $5.2396. These shares were purchased in multiple transactions at prices ranging from $5.19 to $5.24, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- 4. The price reported in Column 4 is a weighted average price of $2.0405. These shares were purchased in multiple transactions at prices ranging from $2.01 to $2.06, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
